Serina Therapeutics, Inc. (SER)
1.65
-0.04
(-2.37%)
USD |
NYAM |
Nov 05, 16:00
Serina Therapeutics Market Cap : 41.91M for Nov. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 41.91M |
| November 04, 2026 | 42.93M |
| November 03, 2026 | 46.48M |
| November 02, 2026 | 46.99M |
| October 30, 2026 | 49.28M |
| October 29, 2026 | 48.01M |
| October 28, 2026 | 41.66M |
| October 27, 2026 | 42.42M |
| October 26, 2026 | 43.43M |
| October 23, 2026 | 41.91M |
| October 22, 2026 | 44.70M |
| October 21, 2026 | 44.96M |
| October 20, 2026 | 42.16M |
| October 19, 2026 | 41.91M |
| October 16, 2026 | 43.69M |
| October 15, 2026 | 45.47M |
| October 14, 2026 | 43.43M |
| October 13, 2026 | 46.23M |
| October 12, 2026 | 49.28M |
| October 09, 2026 | 50.80M |
| October 08, 2026 | 51.05M |
| October 07, 2026 | 51.05M |
| October 06, 2026 | 51.82M |
| October 05, 2026 | 51.82M |
| October 02, 2026 | 49.78M |
| Date | Value |
|---|---|
| October 01, 2026 | 49.53M |
| September 30, 2026 | 50.80M |
| September 29, 2026 | 52.83M |
| September 28, 2026 | 51.05M |
| September 25, 2026 | 53.09M |
| September 24, 2026 | 54.36M |
| September 23, 2026 | 55.63M |
| September 22, 2026 | 58.67M |
| September 21, 2026 | 58.67M |
| September 18, 2026 | 57.15M |
| September 17, 2026 | 56.39M |
| September 16, 2026 | 54.86M |
| September 15, 2026 | 59.69M |
| September 14, 2026 | 62.23M |
| September 11, 2026 | 56.39M |
| September 10, 2026 | 63.50M |
| September 09, 2026 | 65.28M |
| September 08, 2026 | 63.50M |
| September 04, 2026 | 69.34M |
| September 03, 2026 | 68.33M |
| September 02, 2026 | 66.55M |
| September 01, 2026 | 63.50M |
| August 31, 2026 | 61.47M |
| August 28, 2026 | 62.48M |
| August 27, 2026 | 64.01M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.156B |
| Oncolytics Biotech, Inc. | 56.65M |
| Sangamo Therapeutics, Inc. | 47.23M |
| Sarepta Therapeutics, Inc. | 1.896B |
| Anixa Biosciences, Inc. | 104.45M |
Market Cap Related Metrics
| PEG Ratio | -0.0031 |
| Price to Book Value | 2.238 |
| Price | 1.65 |
| Earnings Yield | -113.8% |
| PEGY Ratio | -0.0031 |